TPTX » Topics » Item 8.01 Other Events.

This excerpt taken from the TPTX 8-K filed Oct 5, 2009.

Item 8.01 Other Events.

On September 28, 2009, Rap Pharma issued a press release announcing the results of the votes at the Rap Pharma’s Annual Stockholders’ Meeting and TorreyPines Annual Stockholders’ Meeting. On September 30, 2009, Raptor issued a press release announcing the completion of the Merger and the commencement of Raptor’s common stock trading on the NASDAQ Capital Market, among other things. On October 1, 2009, Raptor issued a press release announcing the appointment of Llew Keltner, M.D., Ph.D., to Raptor’s board of directors, among other

 

 

things. Copies of such press releases are attached hereto as Exhibits 99.1, 99.2 and 99.3 to this Current Report on Form 8-K and are incorporated herein by reference.

 

This excerpt taken from the TPTX 8-K filed Jul 31, 2009.

Item 8.01 Other Events.

On July 30, 2009 TorreyPines issued a press release announcing the cancelation of the Special Meeting of Stockholders originally scheduled for July 9, 2009, which meeting had been adjourned until July 30, 2009, in order to pursue the completion of the Merger with Raptor. A copy of the press release, titled, “TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction,” is attached hereto as Exhibit 99.1.

This excerpt taken from the TPTX 8-K filed Jul 28, 2009.

Item 8.01 Other Events.

On July 28, 2009, Raptor and TorreyPines issued a joint press release announcing the execution of the Merger Agreement. A copy of the press release, titled, “Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement,” is attached hereto as Exhibit 99.1.


On July 24, 2009 TorreyPines’ Board of Directors unanimously approved cancelling the Special Meeting of Stockholders originally scheduled for July 9, 2009, which meeting has been adjourned until July 30, 2009, in order to pursue the completion of the Merger with Raptor.

This excerpt taken from the TPTX 8-K filed Feb 14, 2008.

Item 8.01.              Other Events

 

On February 14, 2008, TorreyPines Therapeutics, Inc. issued a press release announcing the company’s 2008 strategic plan.  The plan will focus on clinical development activities to maximize the value of the company’s lead compounds: AMPA/kainate receptor antagonist tezampanel and NGX426 and the muscarinic agonist NGX267.  As part of the 2008 strategic plan, and in conjuction with the February 28, 2008 conclusion of the gamma-secretase modulator collaboration agreement between the company and Eisai Co., Ltd., the company intends to reduce its work force.  A copy of the press release is attached as Exhibit 99.1

 

The press release announced that TorreyPines will hold a conference call and webcast today at 11:00 a.m. Eastern time to discuss the 2008 strategic plan.

 

This excerpt taken from the TPTX 8-K filed Sep 25, 2007.

Item 8.01.      Other Events

 

On September 25, 2007, TorreyPines Therapeutics, Inc. issued a press release announcing that Eisai Co., Ltd. has elected to extend the term of the Cooperation Agreement between TorreyPines Therapeutics, Inc. and Eisai dated as of October 1, 2005 for an additional twelve months pursuant to the terms of the agreement. A copy of this press release is furnished herewith as Exhibit 99.1. Pursuant to the rules and regulations of the Securities and Exchange Commission, such exhibit and the information set forth therein and in this Item 8.01 have been furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing regardless of any general incorporation language.

 

This excerpt taken from the TPTX 8-K filed Feb 7, 2007.

Item 8.01.              Other Events

On February 5, 2007, we were notified by Eisai Co., Ltd. of its intention to extend the term of the Collaboration Agreement between us and Eisai dated as of February 28, 2005 for an additional twelve months pursuant to the terms of the agreement.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

 

 

 

 

Date: February 6, 2007

 

 

 

 

 

 

By:

 

/s/ Craig Johnson

 

 

Name:

 

Craig Johnson

 

 

Title:

 

Vice President, Finance and

 

 

 

 

Chief Financial Officer

 



This excerpt taken from the TPTX 8-K filed Oct 4, 2006.

Item 8.01. Other Events.

Effective October 4, 2006, in connection with the Company’s corporate name change from “Axonyx Inc.” to “TorreyPines Therapeutics, Inc.,” the Company changed its trading symbol on The Nasdaq Global Stock Market from “AXYX” to “TPTX.”

A copy of the press release announcing the completion of the merger is attached hereto as Exhibit 99.1 and incorporated herein by reference.

This excerpt taken from the TPTX 8-K filed Aug 30, 2006.

Item 8.01 Other Events.

On August 30, 2006, TorreyPines Therapeutics, Inc. issued the press release attached as exhibit 99.1 hereto.

This excerpt taken from the TPTX DEFA14A filed Aug 30, 2006.

Item 8.01 Other Events.

On August 30, 2006, TorreyPines Therapeutics, Inc. issued the press release attached as exhibit 99.1 hereto.

This excerpt taken from the TPTX 8-K filed Aug 7, 2006.

Item 8.01 Other Events.

 

On August 7, 2006, TorreyPines Therapeutics, Inc. issued the press release attached as exhibit 99.1 hereto.

 

This excerpt taken from the TPTX 8-K filed Mar 13, 2006.

Item 8.01 Other Events.

 

On March 8, 2006, Axonyx Inc. issued the press release attached as Exhibit 99.1 hereto.

 

This excerpt taken from the TPTX 8-K filed Jan 6, 2006.

Item 8.01 Other Events.

On January 4, 2006, Axonyx Inc. issued the press release attached as Exhibit 99.1 hereto.

This excerpt taken from the TPTX 8-K filed Sep 20, 2005.

Item 8.01 Other Events.

 

On September 20, 2005, Axonyx Inc. issued the press release attached as Exhibit 99.1 hereto.

 

This excerpt taken from the TPTX 8-K filed Jul 27, 2005.

Item 8.01 Other Events.

 

On July 26, 2005, Axonyx Inc. issued the press release attached as Exhibit 99.1 hereto.

 

This excerpt taken from the TPTX 8-K filed Jun 30, 2005.

Item 8.01 Other Events.

 

On June 30, 2005, the Company announced (i) that Marvin S. Hausman, M.D., has elected to step down as Chairman of the Board of Directors on September 14, 2005, but will remain a director of the Company, and (ii) that the Company’s Board of Directors has unanimously elected Steven B. Ratoff, a current director, to succeed Dr. Hausman as non-executive chairman. A copy of the Company’s press release is attached as Exhibit 99.2 hereto.

 

This excerpt taken from the TPTX 8-K filed Mar 14, 2005.

Item 8.01 Other Events.

 

On March 11, 2005, Axonyx Inc. issued the two press releases attached as Exhibit 99.1 and Exhibit 99.2 hereto.

 

This excerpt taken from the TPTX 8-K filed Feb 7, 2005.

Item 8.01. Other Events.

 

On February 7, 2005, Axonyx Inc. issued the press release attached as Exhibit 99.1 hereto.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki